[Retracted] Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases

Table 3

Comparison of VAS scores.

Groups	Number of cases	VAS score (points)
		Before treatment	After treatment
Control subjects	54
Research group	50
	/	0.896	17.582
	/	>0.05	<0.05